Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized double blind placebo controlled trial comparing Nifedipine 30mg XL to
placebo in 110 patients after decision has been made to proceed with induction of labor for
the diagnosis of preeclampsia with severe features.